Mutations of the human BTK gene coding for Bruton tyrosine kinase in X-linked agammaglobulinemia

被引:0
作者
Vihinen, M
Kwan, SP
Lester, T
Ochs, HD
Resnick, I
Väliaho, J
Conley, ME
Smith, CIE
机构
[1] Univ Tampere, Inst Med Technol, FIN-33101 Tampere, Finland
[2] Rush Med Sch, Dept Immunol, Chicago, IL USA
[3] Great Ormond St Hosp Sick Children, Camelia Botnar Labs, Clin Mol Genet Lab, London WC1N 3JH, England
[4] Univ Washington, Dept Pediat, Seattle, WA 98195 USA
[5] Cent Republ Paediat Hosp, Res Inst Paediat Hematol, Dept Clin Immunol, Moscow, Russia
[6] St Jude Childrens Res Hosp, Dept Immunol, Memphis, TN 38105 USA
[7] Karolinska Inst, Dept Biosci, Ctr Biotechnol, Huddinge, Sweden
[8] Huddinge Univ Hosp, Karolinska Inst, Dept Immunol Microbiol Pathol & Infect Dis, S-14186 Huddinge, Sweden
关键词
Bruton agammaglobulinemia tyrosine kinase; BTK; BTKbase; XLA; X-linked agammaglobulinemia; database; immunodeficiency;
D O I
10.1002/(SICI)1098-1004(1999)13:4<280::AID-HUMU3>3.0.CO;2-L
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
X-linked agammaglobulinemia (XLA) is an immunodeficiency caused by mutations in the gene coding for Bruton agammaglobulinemia tyrosine kinase (BTK), A database (BTKbase) of BTX mutations lists 544 mutation entries from 471 unrelated families showing 341 unique molecular events. In addition to mutations, a number of variants or polymorphisms have been found. Mutations in all the five domains of BTK cause the disease, the single most common event being missense mutations. Most mutations lead to truncation of the enzyme, The mutations appear almost uniformly throughout the molecule. About one-third of point mutations affect CpG sites, which usually code for arginine residues. The putative structural implications of all the missense mutations are provided in the database. BTKbase is available at http://www.uta.fi/imt/bioinfo. Hum Mutat 13:280-285, 1999, (C) 1999 Wiley-Liss, Inc.
引用
收藏
页码:280 / 285
页数:6
相关论文
共 34 条
  • [1] Mutations in Btk in patients with presumed X-linked agammaglobulinemia
    Conley, ME
    Mathias, D
    Treadaway, J
    Minegishi, Y
    Rohrer, J
    [J]. AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (05) : 1034 - 1043
  • [2] Mutation of the pleckstrin homology domain of Bruton's tyrosine kinase in immunodeficiency impaired inositol 1,3,4,5-tetrakisphosphate binding capacity
    Fukuda, M
    Kojima, T
    Kabayama, H
    Mikoshiba, K
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (48) : 30303 - 30306
  • [3] Futatani T, 1998, BLOOD, V91, P595
  • [4] CLOSE LINKAGE OF PROBE-P212 (DXS178) TO X-LINKED AGAMMAGLOBULINEMIA
    GUIOLI, S
    ARVEILER, B
    BARDONI, B
    NOTARANGELO, LD
    PANINA, P
    DUSE, M
    UGAZIO, A
    OBERLE, I
    DESAINTBASILE, G
    MANDEL, JL
    CAMERINO, G
    [J]. HUMAN GENETICS, 1989, 84 (01) : 19 - 21
  • [5] Solution structure of the SH3 domain from Bruton's tyrosine kinase
    Hansson, H
    Mattsson, PT
    Allard, P
    Haapaniemi, P
    Vihinen, M
    Smith, CIE
    Härd, T
    [J]. BIOCHEMISTRY, 1998, 37 (09) : 2912 - 2924
  • [6] Structure of the PH domain and Btk motif from Bruton's tyrosine kinase: Molecular explanations for X-linked agammaglobulinaemia
    Hyvonen, M
    Saraste, M
    [J]. EMBO JOURNAL, 1997, 16 (12) : 3396 - 3404
  • [7] The G protein Gα12 stimulates Bruton's tyrosine kinase and a rasGAP through a conserved PH/BM domain
    Jiang, Y
    Ma, W
    Wan, Y
    Kozasa, T
    Hattori, S
    Huang, XY
    [J]. NATURE, 1998, 395 (6704) : 808 - 813
  • [8] MAPPING OF THE X-LINKED AGAMMAGLOBULINEMIA LOCUS BY USE OF RESTRICTION-FRAGMENT-LENGTH-POLYMORPHISM
    KWAN, SP
    KUNKEL, L
    BRUNS, G
    WEDGWOOD, RJ
    LATT, S
    ROSEN, FS
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (02) : 649 - 652
  • [9] Identification of the binding site for Gqα on its effector Bruton's tyrosine kinase
    Ma, YC
    Huang, XY
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (21) : 12197 - 12201
  • [10] MATTSSON P, 1996, BIOESSAYS, V10, P825